Conflict of Interest Disclosures

Editor-In-Chief

Beth Faiman, PhD, MSN, APRN-BC, AOCN®, FAAN, has served as a consultant for Bristol Myers Squibb, Karyopharm Therapeutics, and Sanofi.

Associate Editors

Denice Economou, PhD, MSN, CHPN, has no conflicts of interest to disclose.

Theresa Wicklin Gillespie, PhD, MA, RN, FAAN, has no conflicts of interest to disclose.

Carolyn Grande, CRNP, AOCNP®, has served as a consultant for AstraZeneca and Pfizer.

Kirollos Hanna, PharmD, BCPS, BCOP, has served as a consultant for AbbVie and Seattle Genetics, on advisory boards for AstraZeneca, Heron Therapeutics, Incyte, Rigel, Sandoz, Taiho Oncology, on the speakers bureaus for AbbVie, Astellas, BeiGene, Bristol Myers Squibb, and Seattle Genetics, and holds stock in CVS Health.

Sandra E. Kurtin, PhD, ANP-C, AOCN®, has served as a consultant for AbbVie, Acceleron, Amgen, Celgene, Genentech, Incyte, Novartis, and Pharmacyclics.

Lindsey Lyle, MS, PA-C, has served as a consultant for Agios, Celgene, Incyte Corporation, Novartis, Takeda Oncology, and Pfizer.

Lydia T. Madsen, PhD, RN, AOCNS®, FNAP, has no conflicts of interest to disclose.

Beth Sandy, MSN, CRNP, OCN®, has served on speakers bureaus for AbbVie, AstraZeneca, Helsinn, Merck, and Takeda.

Constance Visovsky, PhD, RN, ACNP-BC, has no conflicts of interest to disclose.

Wendy H. Vogel, MSN, FNP, AOCNP®, has no conflicts of interest to disclose.

Steven H. Wei, MS, MPH, PA-C, DFAAPA, has no conflicts of interest to disclose.

Rita Wickham, PhD, RN, AOCN®, has served on the speakers bureau for Genentech and as a consultant for Insys Therapeutics.